RE-irradiation of Diffuse MIdline Glioma paTients

Clinical trial NCT06093165 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06093165
Sponsor: Rigshospitalet, Denmark
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diffuse Midline Glioma, H3 K27M-Mutant Diffuse Intrinsic Pontine Glioma Diffuse Glioma Pontine Tumors Thalamic Tumor Brain Tumor, Pediatric

Start date: 2023-10-01
Primary completion: 2029-11-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.